Martín-Carbonero L - Search Results

1

Severe liver disease associated with prolonged exposure to antiretroviral drugs.

Maida I, Núñez M, Ríos MJ, Martín-Carbonero L, Sotgiu G, Toro C, Rivas P, Barreiro P, Mura MS, Babudieri S, Garcia-Samaniego J, González-Lahoz J, Soriano V. Maida I, et al. J Acquir Immune Defic Syndr. 2006 Jun;42(2):177-82. doi: 10.1097/01.qai.0000221683.44940.62. J Acquir Immune Defic Syndr. 2006. PMID: 16688096

2

Normalization of liver enzymes in an HIV-hepatitis C virus-co-infected patient after potent antiretroviral therapy.

Diaz B, Martín-Carbonero L, Pérez-Olmeda M, Soriano V. Diaz B, et al. AIDS. 2002 May 24;16(8):1193. doi: 10.1097/00002030-200205240-00018. AIDS. 2002. PMID: 12004283 No abstract available.

3

SENC (Spanish efavirenz vs. nevirapine comparison) trial: a randomized, open-label study in HIV-infected naive individuals.

Núñez M, Soriano V, Martín-Carbonero L, Barrios A, Barreiro P, Blanco F, García-Benayas T, González-Lahoz J. Núñez M, et al. HIV Clin Trials. 2002 May-Jun;3(3):186-94. doi: 10.1310/0cj5-2abq-cb00-6mr6. HIV Clin Trials. 2002. PMID: 12032877 Clinical Trial.

4

Role of hepatitis C virus genotype in the development of severe transaminase elevation after the introduction of antiretroviral therapy.

Núñez M, Ríos P, Martín-Carbonero L, Pérez-Olmeda M, González-Lahoz J, Soriano V. Núñez M, et al. J Acquir Immune Defic Syndr. 2002 May 1;30(1):65-8. doi: 10.1097/00042560-200205010-00008. J Acquir Immune Defic Syndr. 2002. PMID: 12048364

5

Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution.

Martín-Carbonero L, Núñez M, Ríos P, Pérez-Olmeda M, González-Lahoz J, Soriano V. Martín-Carbonero L, et al. AIDS. 2002 Jul 5;16(10):1423-5. doi: 10.1097/00002030-200207050-00016. AIDS. 2002. PMID: 12131221

6

Salvage treatment with lopinavir/ritonavir (Kaletra) in HIV-infected patients failing all current antiretroviral drug families.

de Mendoza C, Martín-Carbonero L, Barreiro P, Diaz B, Valencia E, Jiménez-Nácher I, Gallego O, Núñez M, González-Lahoz J, Soriano V. de Mendoza C, et al. HIV Clin Trials. 2002 Jul-Aug;3(4):304-9. doi: 10.1310/h5jn-mfg3-g35k-qx9j. HIV Clin Trials. 2002. PMID: 12187504

7

[Spectrum of diseases in patients hospitalized with HIV infection in the HAART era].

Valencia ME, Martín-Carbonero L, López M, Soriano V, Moreno V, González Lahoz J. Valencia ME, et al. Med Clin (Barc). 2002 Sep 14;119(8):293-5. Med Clin (Barc). 2002. PMID: 12236969 Spanish.

8

Evolution of the gp41 env region in HIV-infected patients receiving T-20, a fusion inhibitor.

Poveda E, Rodés B, Toro C, Martín-Carbonero L, Gonzalez-Lahoz J, Soriano V. Poveda E, et al. AIDS. 2002 Sep 27;16(14):1959-61. doi: 10.1097/00002030-200209270-00014. AIDS. 2002. PMID: 12351957 No abstract available.

9

Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors.

Barreiro P, Camino N, de Mendoza C, Valer L, Núñez M, Martín-Carbonero L, González-Lahoz J, Soriano V. Barreiro P, et al. Int J Antimicrob Agents. 2002 Dec;20(6):438-43. doi: 10.1016/s0924-8579(02)00250-9. Int J Antimicrob Agents. 2002. PMID: 12458138 Clinical Trial.

10

Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?

Soriano V, Martín-Carbonero L, García-Samaniego J. Soriano V, et al. AIDS. 2003 Mar 28;17(5):751-3. doi: 10.1097/01.aids.0000050824.06065.cd. AIDS. 2003. PMID: 12646800 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters